EMERGING GLUCOSE MEDICATIONS : SAXENDA, RYBELSUS & MOUNJARO IN THE BRITAIN

Several novel medications are now present in the United Kingdom for treating diabetes type 2 . Saxenda, Januvia , and Mounjaro represent distinct approaches, with copyright and Jardiance being injectable GLP-1 receptor mimics primarily aimed at weight management alongside sugar levels stabilizati